Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD

10.56  +0.03 (+0.28%)

After market: 10.56 0 (0%)

Fundamental Rating

4

Overall CLB gets a fundamental rating of 4 out of 10. We evaluated CLB against 61 industry peers in the Energy Equipment & Services industry. CLB has only an average score on both its financial health and profitability. CLB has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CLB had positive earnings in the past year.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
CLB had a positive operating cash flow in each of the past 5 years.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CLB has a Return On Assets (4.92%) which is comparable to the rest of the industry.
CLB has a Return On Equity of 11.34%. This is in the better half of the industry: CLB outperforms 67.21% of its industry peers.
With a decent Return On Invested Capital value of 9.07%, CLB is doing good in the industry, outperforming 68.85% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CLB is in line with the industry average of 8.05%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.07%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.92%
ROE 11.34%
ROIC 9.07%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

With a Profit Margin value of 5.73%, CLB perfoms like the industry average, outperforming 54.10% of the companies in the same industry.
In the last couple of years the Profit Margin of CLB has declined.
CLB has a Operating Margin (10.93%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLB has declined.
The Gross Margin of CLB (19.56%) is worse than 72.13% of its industry peers.
CLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.93%
PM (TTM) 5.73%
GM 19.56%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

6

2. Health

2.1 Basic Checks

CLB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLB has more shares outstanding
The debt/assets ratio for CLB has been reduced compared to a year ago.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CLB has an Altman-Z score of 2.68. This is not the best score and indicates that CLB is in the grey zone with still only limited risk for bankruptcy at the moment.
CLB's Altman-Z score of 2.68 is fine compared to the rest of the industry. CLB outperforms 77.05% of its industry peers.
The Debt to FCF ratio of CLB is 3.17, which is a good value as it means it would take CLB, 3.17 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.17, CLB is in the better half of the industry, outperforming 63.93% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that CLB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.48, CLB perfoms like the industry average, outperforming 47.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.17
Altman-Z 2.68
ROIC/WACC1.03
WACC8.81%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.27 indicates that CLB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.27, CLB is in the better half of the industry, outperforming 70.49% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that CLB should not have too much problems paying its short term obligations.
The Quick ratio of CLB (1.70) is better than 70.49% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.7
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

CLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.44%.
The earnings per share for CLB have been decreasing by -13.14% on average. This is quite bad
The Revenue has been growing slightly by 0.71% in the past year.
CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)-2.44%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-13.64%
Revenue 1Y (TTM)0.71%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-0.32%

3.2 Future

The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
Based on estimates for the next years, CLB will show a small growth in Revenue. The Revenue will grow by 3.47% on average per year.
EPS Next Y-11.91%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-2.96%
Revenue Next 2Y-0.4%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.20 indicates a correct valuation of CLB.
63.93% of the companies in the same industry are more expensive than CLB, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, CLB is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 12.82, the valuation of CLB can be described as correct.
CLB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of CLB to the average of the S&P500 Index (36.42), we can say CLB is valued rather cheaply.
Industry RankSector Rank
PE 13.2
Fwd PE 12.82
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLB is valued a bit more expensive than the industry average as 73.77% of the companies are valued more cheaply.
CLB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 12.61
EV/EBITDA 8.26
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.37%, CLB is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.89, CLB has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, CLB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.37%

5.2 History

The dividend of CLB decreases each year by -55.13%.
CLB has been paying a dividend for at least 10 years, so it has a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

6.33% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP6.33%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

More info and screens

CORE LABORATORIES INC

NYSE:CLB (8/4/2025, 8:04:00 PM)

After market: 10.56 0 (0%)

10.56

+0.03 (+0.28%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)N/A N/A
Inst Owners117.5%
Inst Owner Change-0.22%
Ins Owners1.04%
Ins Owner Change3.93%
Market Cap495.16M
Analysts50
Price Target14.69 (39.11%)
Short Float %16.6%
Short Ratio15.9
Dividend
Industry RankSector Rank
Dividend Yield 0.37%
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP6.33%
Div Incr Years0
Div Non Decr Years3
Ex-Date08-04 2025-08-04 (0.01)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.5%
Min EPS beat(2)-4.67%
Max EPS beat(2)-0.33%
EPS beat(4)1
Avg EPS beat(4)0.47%
Min EPS beat(4)-4.67%
Max EPS beat(4)7.15%
EPS beat(8)3
Avg EPS beat(8)3.08%
EPS beat(12)7
Avg EPS beat(12)5.69%
EPS beat(16)7
Avg EPS beat(16)2.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)0.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)3
Avg Revenue beat(12)-1.39%
Revenue beat(16)4
Avg Revenue beat(16)-1.45%
PT rev (1m)-1.37%
PT rev (3m)-14.29%
EPS NQ rev (1m)6.09%
EPS NQ rev (3m)-9.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.69%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)-5.05%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)-4.68%
Valuation
Industry RankSector Rank
PE 13.2
Fwd PE 12.82
P/S 0.96
P/FCF 12.61
P/OCF 9.12
P/B 1.9
P/tB 3.19
EV/EBITDA 8.26
EPS(TTM)0.8
EY7.58%
EPS(NY)0.82
Fwd EY7.8%
FCF(TTM)0.84
FCFY7.93%
OCF(TTM)1.16
OCFY10.97%
SpS11.03
BVpS5.57
TBVpS3.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.92%
ROE 11.34%
ROCE 11.37%
ROIC 9.07%
ROICexc 9.68%
ROICexgc 12.53%
OM 10.93%
PM (TTM) 5.73%
GM 19.56%
FCFM 7.59%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexcg growth 3Y11.32%
ROICexcg growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score6
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.17
Debt/EBITDA 1.75
Cap/Depr 101.97%
Cap/Sales 2.9%
Interest Coverage 6.2
Cash Conversion 76.15%
Profit Quality 132.56%
Current Ratio 2.27
Quick Ratio 1.7
Altman-Z 2.68
F-Score6
WACC8.81%
ROIC/WACC1.03
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.44%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-13.64%
EPS Next Y-11.91%
EPS Next 2Y-3.25%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)0.71%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%-0.32%
Revenue Next Year-2.96%
Revenue Next 2Y-0.4%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-2.45%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year11.28%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y151.78%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y119.82%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%